Clinical trials put people at risk, which is one of the reasons why they need prior authorisation. It is perfectly permissible and desirable for the authorities to set conditions to try to ensure the maximum public benefit from such trials. If anyone owns the results of clinical trials it is the volunteers who participated, and who put themselves at greater or lesser risk. <p>Pharmaceutical companies and their lawyers will continue to proclaim their commitment to transparency while also seeking to retain the maximum control over that what they disclose. They will argue against enhanced transparency in the debate over the proposed regulation on clinical trials, and in their case before the European Court. Their position is wrong. Worse, it is morally repugnant.